Back

Qualia NAD+(R) Increases NAD+, Improves Well-Being, and Alleviates Aging Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study

Blomquist, S.; Kelly, G.; Adaes, S.; Ardagh, A.; Ramer, S.; Scuba, W.

2025-05-16 nutrition
10.1101/2025.05.14.25327611 medRxiv
Show abstract

A key factor in aging and many age-related diseases is the decline in nicotinamide adenine dinucleotide (NAD+) levels. Preclinical studies demonstrate promising results for NAD+ boosting in improving conditions of disease or aging. However, only a limited number of human studies have shown meaningful improvements in physiological function or quality of life with NAD+ boosting supplements. This randomized, double-blind, placebo-controlled study (Clinicaltrails.gov identifier: NCT06505967) investigated the impact of Qualia NAD+(R), a novel NAD+ supporting nutraceutical containing nicotinamide riboside (NR) and a variety of synergistic vitamins, minerals, and botanicals, on blood NAD+ levels and healthy aging, as assessed by quality of life surveys. MethodsStudy participants were randomly allocated to consume either Qualia NAD+ or placebo for 28 days. NAD+ levels were measured at baseline and study end using a validated, self-administered, dried blood spot assay. Quality of life measures were assessed weekly. Independent samples t-tests were used to compare NAD+ levels between study arms. Questionnaire data were compared using linear mixed-effects regression modeling. ResultsSixty-three healthy adults (n = 28 Qualia NAD+, n=35 placebo) enrolled in the study and had their NAD+ levels assessed. Qualia NAD+ increased NAD+ levels by 67% compared to 4% with placebo (p < 0.001). Qualia NAD+ improved emotional well-being versus placebo at multiple timepoints (p < 0.05). Aging female symptoms improved in overall and somatic categories at day 28 (p < 0.05). No improvements in aging symptoms were observed for males. ConclusionsQualia NAD+ increased NAD+ levels, enhanced quality of life in all participants, and alleviated some aging symptoms in females greater than placebo. The increase in NAD+ levels with Qualia NAD+ was greater than in most previous clinical trials of NAD+ supporting products at similar dosing, suggesting potential synergy between NR and the complementary nutrients in the product.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
npj Aging
15 papers in training set
Top 0.1%
40.9%
2
Aging Cell
144 papers in training set
Top 0.4%
18.2%
50% of probability mass above
3
The Journals of Gerontology: Series A
25 papers in training set
Top 0.2%
5.0%
4
Frontiers in Nutrition
23 papers in training set
Top 0.4%
3.4%
5
The American Journal of Clinical Nutrition
19 papers in training set
Top 0.1%
3.2%
6
GeroScience
97 papers in training set
Top 0.7%
2.5%
7
Current Developments in Nutrition
15 papers in training set
Top 0.3%
2.5%
8
Aging
69 papers in training set
Top 0.9%
2.5%
9
Nutrients
64 papers in training set
Top 0.7%
2.2%
10
Food & Function
12 papers in training set
Top 0.2%
2.0%
11
PLOS ONE
4510 papers in training set
Top 52%
1.8%
12
Journal of the American Geriatrics Society
12 papers in training set
Top 0.1%
1.7%
13
Nature Communications
4913 papers in training set
Top 55%
1.3%
14
Clinical Epigenetics
53 papers in training set
Top 0.7%
1.2%
15
Scientific Reports
3102 papers in training set
Top 70%
0.9%
16
Journal of Translational Medicine
46 papers in training set
Top 2%
0.8%
17
BMJ Nutrition, Prevention & Health
10 papers in training set
Top 0.6%
0.7%
18
Annals of Neurology
57 papers in training set
Top 2%
0.7%
19
Science Translational Medicine
111 papers in training set
Top 7%
0.7%
20
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
22 papers in training set
Top 0.4%
0.7%
21
eLife
5422 papers in training set
Top 62%
0.5%